Funnelfeedr Logo

DiaBridge AB

Sweden556979-7995Active

Developing breakthrough drugs targeting DNA repair for cancer and inflammation.

Biotechnology/Pharmaceutical Companyoxcia.com

Overview

0
Employees
0 SEK
Revenue
2014
Founded

Key Decision Makers

Ulrika Warpman Berglund

CEO

@oxcia.com+46732XXXXXX

Monika Vedin

Business strategy & Communication Director

@oxcia.com

Christina Kalderén

Preclinical Director

@oxcia.com

Austin Smith

Chief Medical Officer

@oxcia.com

+5 more contacts in Funnelfeedr

Description

Oxcia AB is a science-led Swedish biotechnology company focused on revolutionizing treatments for cancer and inflammation. The core of their innovation lies in the unique O2-DDR technology platform, which manages oxidative stress, oxidative DNA damage, and the DNA Damage Response (DDR) in cells. Thi...

Tags

B2BPharmaceuticalsProfessional ServicesTechnologyWhite Collar

Keywords

BiotechClinical DevelopmentDDRDrug DiscoveryFibrosisOncologyOxidative Stress

Tech Stack

jQueryVimeoWordPressCookiebotYouTubeGoogle Analytics

Company Information

Industry
Annan naturvetenskaplig och teknisk forskning och utveckling
Legal Form
Aktiebolag
VAT Number
SE556979799501

Decision Makers

9 contacts in Funnelfeedr

Ulrika Warpman Berglund

CEO

@oxcia.com+46732XXXXXX

Monika Vedin

Business strategy & Communication Director

@oxcia.com

Christina Kalderén

Preclinical Director

@oxcia.com

Austin Smith

Chief Medical Officer

@oxcia.com

Ingvar Karlsson

Member of the Board

@oxcia.com

Thomas Helleday

Member of the Board

@oxcia.com

Eva Sjökvist Saers

Chairman of the board

@saers.com

Håkan Nordlander

Head Administration and Accounting

@oxcia.com

Gustaf Eriksson

Sales and Marketing Manager

@atek.nu+46708XXXXXX

Similar Companies

20 similar companies in Funnelfeedr

Browse More

DiaBridge AB Questions

Want to see Funnelfeedr in action?

Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.

Book a demo